This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2024 — Pharmaceutical Compliance Congress


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
April 16-18, 2024The Ritz-Carlton, Tysons Corner | McLean, VA

Michael Hercz
Senior Vice President & General Counsel at Sentynl Therapeutics Inc.


Michael has over 25 years of diverse Life Sciences legal, regulatory, compliance and risk management experience. He currently serves as General Counsel and Chief Compliance Officer of Sentynl Therapeutics, Inc. Prior to Sentynl, Michael served in senior roles at Deloitte & Touche (Managing Director), Victory Pharmaceuticals (VP and Chief Compliance Officer), and Amgen Inc. (Executive Director). He also practiced at Akin, Gump, Strauss, Hauer & Feld LLP and Hooper, Lundy & Bookman Inc. where he represented exclusively life sciences and healthcare entities. He earned his B.A. from the University of Pennsylvania and his J.D. from the University of Southern California.

Agenda Sessions

  • PSPs and PAPs– A Look at the Evolution, Risks and Enforcement Activity